Organization’s Boards spans state, industry segments to provide unique blend of expertise for advancing South Carolina’s life sciences industry
GREENVILLE, SC – February 8, 2019 – Less than two years after initiating a comprehensive relaunch of the state’s official life sciences organization, SCBIO has expanded its Board of Directors for its 501c6 operational entity and added a second 10-member Board for its 501c3 research and educational arm for 2019. It does so having authored the state’s first-ever life sciences strategic growth plan, conducted an economic impact study validating the contributions of the $11.4 billion industry, tripled revenues and quadrupled membership – all since Spring 2017.
And according to SCBIO President and CEO Sam Konduros, the best and most exciting days for the industry and organization are still ahead of it.
“In a state perhaps best known for building BMWs and Boeing Dreamliners, there is a very strong life sciences story brewing as well, creating opportunities to diversify and accelerate growth of our state’s knowledge economy,” said Konduros recently. He further cited rapid growth of such national and global brands including Nephron Pharmaceuticals, Arthrex, ZEUS, Abbott, Thorne and AVX as just a few examples of the state’s rapidly rising life sciences industry, which currently spans more than 400 companies in 44 counties and employs over 15,000 well-paid associates.
Leading the policy- and strategy-making efforts of the 501c6 entity of the non-profit organization, the Board of Directors meets regularly to receive updates on SCBIO business objectives, domestic and global initiatives, and to help hone strategies and offer insight. Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve as SCBIO’s 2019 Board Chair; Stephanie Yarbrough, Womble Bond Dickinson, LLP as Vice Chair; Michael Rusnak, Medical University of South Carolina Research Foundation as Treasurer; and Josh Ridley of ZEUS as Secretary.
Jeff Stover of Haynsworth Sinkler Boyd, PA will serve as Legal Officer; Heather Simmons Jones of the Greenwood Partnership Alliance as Annual Conference Officer; Bryan Davis of Prisma/Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; Adam Hoots of DPR Construction as Talent/Workforce Officer; and Sam Konduros, President and CEO of SCBIO.
Recently added members of the SCBIO Board of Directors are:
Mike Briggs – President & CEO, Central SC Alliance
Caroline Brown – Director of External Affairs, Medical University of South Carolina
Thornton Kirby – President & CEO, South Carolina Hospital Association
Adam Klonecke – Senior Site Director, Abbott
Angie Leidinger – VP of External Affairs, Clemson University
Tom McKenna – Chief Operating Officer, Thorne
Robert Ryan – CEO & Founder, Innova Therapeutics
Dave Shalaby – President, Poly-Med, Inc.
Will Williams – President & CEO, Economic Development Partnership (Aiken)
Cynthia Young – Dean, Clemson University College of Science
Returning members of the SCBIO Board for 2019 are:
Mandy Brawley – South Carolina Department of Commerce
Matthew Couvillion – Wyche Law Firm
John J. Darby – Johnson & Johnson Services
Tressa Gardner – SE Institute of Manufacturing & Technology
Mike Graney – Charleston Regional Development Alliance
Chad Hardaway – University of South Carolina Office of Economic Engagement
Will Harms – Blue Cross Blue Shield of SC
Erica Jackson – K&L Gates
Marc Metcalf – Upstate SC Alliance
Kathy Phlegar – Phlegar & Associates
Christine Dixon Thiesing – SCRA
Courtney Warren – Marsh & McLennan Agency
Comprising the smaller Board of SCBIO’s 501c3 research and educational arm are Kathryn Becker of Translational Science Solutions; Michael Bolick of Treis Blockchain; Matthew Couvillion of Wyche Law Firm; Shontavia Johnson of Clemson University; Steve Johnson of SCRA; Chris Przirembel, retired Clemson University executive; Shawn Regan of Rhythmlink; Craig Walker of Hitachi Healthcare Americas; Erica Jackson of K&L Gates; and SCBIO CEO Sam Konduros.
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in advanced medicines, medical devices, diagnostics, IT, and healthcare outcome industries.
SCBIO is the official state affiliate of BIO — the world’s largest trade association representing biotechnology organizations. SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.